Skip to content

VAC-Stent Registry

Data Collection on the Treatment of Gastrointestinal Leakage by the Use of Combination of Covered Nitinol Stent and Negative Pressure Wound Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04884334
Enrollment
110
Registered
2021-05-13
Start date
2020-07-01
Completion date
2026-04-01
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perforation of the Colon, Perforation of the Oesophagus

Keywords

Perforation Oesophagus, Oesophageal Anastomotic Leak, endoscopic vacuum therapy, Perforation Colon

Brief summary

This registry is intended to collect data on quality assurance and use of the VAC-Stent® and thus verify the suitability of the VAC-Stent® for sealing leakages in the oesophagus or colon. Furthermore, the safety and efficacy of the VAC-Stent® shall be proven.

Detailed description

For this registry, quality assurance data will be prospectively collected from all patients who receive the VAC-Stent®. The VAC-Stent® combines a vacuum sponge, which lies intraluminal and conditions the wound, with a covered stent, which seals the sponge from the lumen and thus ensures passage. Due to its design, the new medical device VAC-Stent® offers a solution for the most important problems of the covered stent, the stent migration and the lack of drainage function, as well as for those of the endoluminal vacuum sponge, the blockage of the gastrointestinal lumen and the difficult application. The VAC-Stent® is the technical advancement for all indications of the covered stent and for the indication of the endoluminal vacuum sponge, so that a very good effectiveness with reduced complications can be expected for these clinical situations. The VAC-Stent® therefore offers the prospect of an innovative further development in the endoscopic treatment of leaks in the gastrointestinal tract, without any new and unknown risks being associated with it. The primary aim of this registry is to collect data on the quality assurance and application of the VAC-Stent® and thus to evaluate the suitability of the VAC-Stent® for sealing leaks in the oesophagus or colon. In addition, the safety and efficacy of the VAC-Stent® will be demonstrated.

Interventions

DEVICEVAC-Stent®

treatment with the VAC-Stent®

Sponsors

Markus M. Heiss
Lead SponsorOTHER
VAC Stent GmbH
CollaboratorUNKNOWN
Möller Medical GmbH
CollaboratorUNKNOWN
MicroTech Europe GmbH
CollaboratorUNKNOWN
University of Witten/Herdecke
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* written informed consent * treatment with the VAC-Stent®

Exclusion criteria

\- accommodation in an institution under court or administrative order

Design outcomes

Primary

MeasureTime frame
Successful treatment of the leakage with the VAC-Stent®up to 6 months

Secondary

MeasureTime frame
Rate of morphological healing of the insufficiencyapproximately 4 weeks after end of treatment
Number of Participants with complicationsapproximately 4 weeks after end of treatment

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026